EN IT

Kyverna Therapeutics drops 12.2%: the short is back near breakeven after six weeks

Kyverna Therapeutics weekly technical analysis: the stock drops 12.2% as sellers retake control after last week's bounce, and the swing short under management climbs back near breakeven thanks to the fresh leg lower.

Kyverna Therapeutics drops 12.2%: the short is back near breakeven after six weeks
Kyverna Therapeutics, short under management for 6 weeks
Kyverna Therapeutics drops 12.2%: the short is back near breakeven after six weeks
July 17, 2026
Kyverna Therapeutics, short under management for 6 weeks
Our view last week
Kyverna Therapeutics' weekly technical picture shows a 4.6% drop, after three weeks of gains had chipped away at the sell signal under management. The price found a double bottom in the 7.6 area and rebounded 8%, but sellers took back control into the close, with more than 90% of the week's volume on the sell side. The short remains down 13.6% since entry, squeezed between the 8.55 area and the 8.42 area.
This week's summary
Kyverna Therapeutics' sell signal has teeth again: after last week's bounce, the week just closed shed 12.2%, with 80% of volume back on the sell side and money flow sinking deeply negative once more. The daily chart still carved out a double bottom in the 7.3 area, with an intermediate 43% rebound before sellers took back control. The short, under pressure last week, is back near breakeven.
Ongoing decline ·7th week from start ·US stocks ·T2 ★ See Gold version →
IQS Phase
76
in tension
Signal Strength
51
downtrend making lower lows, pace holding
Sizing
STANDARD
Ranking
#63 / 140
US stocks
Trade P&L %
+0.27%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn